Q/C Technologies, Inc. Goodwill
Q/C Technologies, Inc. (QCLS) had Goodwill of $10.50 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-12
- 2026-06-30: Goodwill $10.50M.
- 2026-03-31: Goodwill $10.50M.
- 2025-12-31: Goodwill $10.50M.
- 2025-09-30: Goodwill $10.50M.
| Period end | Goodwill |
|---|---|
| 2026-06-30 | $10.50M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $10.50M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $10.50M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $10.50M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $10.50M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $10.50M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $10.50M 10-K · filed 2026-04-15 |
| 2024-09-30 | $10.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $10.50M 10-Q · filed 2024-08-19 |
| 2024-03-31 | $10.50M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $10.50M 10-K · filed 2025-04-11 |
| 2023-09-30 | $10.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $10.50M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.50M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $10.50M 10-K · filed 2024-04-01 |
| 2022-09-30 | $10.50M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $10.50M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $10.50M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $10.50M 10-K · filed 2023-03-31 |
| 2021-09-30 | $10.50M 10-Q/A · filed 2021-11-15 |
| 2021-06-30 | $10.50M 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |